Clinical trial
A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik® Versus Polyethylene Glycol Preparation (Local Standard of Care) in Children Aged 9 Years to 16 Years
NCT01928862 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik® Versus Polyethylene Glycol Preparation (Local Standard of Care) in Children Aged 9 Years to 16 Years
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 3, 2014
- Completion date
- March 16, 2017
- Enrollment
- 78 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
need for bowel preparation